Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies
- PMID: 21073310
- PMCID: PMC3527891
- DOI: 10.2217/fmb.10.107
Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies
Abstract
Human papillomaviruses (HPVs) cause diseases ranging from benign warts to invasive tumors. A subset of these viruses termed 'high risk' infect the cervix where persistent infection can lead to cervical cancer. Although many HPV genomes have been sequenced, knowledge of virus gene expression and its regulation is still incomplete. This is due in part to the lack, until recently, of suitable systems for virus propagation in the laboratory. HPV gene expression is polycistronic initiating from multiple promoters. Gene regulation occurs at transcriptional, but particularly post-transcriptional levels, including RNA processing, nuclear export, mRNA stability and translation. A close association between the virus replication cycle and epithelial differentiation adds a further layer of complexity. Understanding HPV mRNA expression and its regulation in the different diseases associated with infection may lead to development of novel diagnostic approaches and will reveal key viral and cellular targets for development of novel antiviral therapies.
Figures




Similar articles
-
Papillomavirus genome structure, expression, and post-transcriptional regulation.Front Biosci. 2006 Sep 1;11:2286-302. doi: 10.2741/1971. Front Biosci. 2006. PMID: 16720315 Free PMC article. Review.
-
Searching for antiviral drugs for human papillomaviruses.Antivir Ther. 2000 Dec;5(4):229-42. Antivir Ther. 2000. PMID: 11142617 Review.
-
Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.Viruses. 2017 Aug 30;9(9):245. doi: 10.3390/v9090245. Viruses. 2017. PMID: 28867768 Free PMC article. Review.
-
The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221. doi: 10.1042/CS20160786. Print 2017 Sep 1. Clin Sci (Lond). 2017. PMID: 28798073 Review.
-
Molecular targets for papillomavirus therapy.Curr Drug Targets Infect Disord. 2003 Sep;3(3):221-39. doi: 10.2174/1568005033481105. Curr Drug Targets Infect Disord. 2003. PMID: 14529355 Review.
Cited by
-
Current status and future directions for the development of human papillomavirus vaccines.Front Immunol. 2024 Jun 25;15:1362770. doi: 10.3389/fimmu.2024.1362770. eCollection 2024. Front Immunol. 2024. PMID: 38983849 Free PMC article. Review.
-
The landscape of alternative splicing in cervical squamous cell carcinoma.Onco Targets Ther. 2014 Dec 22;8:73-9. doi: 10.2147/OTT.S72832. eCollection 2015. Onco Targets Ther. 2014. PMID: 25565867 Free PMC article.
-
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives.Front Cell Infect Microbiol. 2022 Jul 4;12:909223. doi: 10.3389/fcimb.2022.909223. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35860379 Free PMC article. Review.
-
Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis.BMC Public Health. 2023 Jul 17;23(1):1369. doi: 10.1186/s12889-023-16305-3. BMC Public Health. 2023. PMID: 37461006 Free PMC article.
-
Interpretations on the Interaction between Protein Tyrosine Phosphatase and E7 Oncoproteins of High and Low-Risk HPV: A Computational Perception.ACS Omega. 2021 Jun 17;6(25):16472-16487. doi: 10.1021/acsomega.1c01619. eCollection 2021 Jun 29. ACS Omega. 2021. PMID: 34235319 Free PMC article.
References
-
- zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virol. 2009;384:260–5. - PubMed
-
- de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virol. 2004;324:17–24. - PubMed
-
- Stanley MA. Human papillomavirus vaccines. Rev. Med. Virol. 2006;16:139–49. - PubMed
-
- Doorbar J, Foo C, Coleman N, et al. Characterisation of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virol. 1997;238:40–52. - PubMed
-
- Graham SV. Late events in the life cycle of human papillomaviruses. In: Campo MS, editor. Papillomavirus research: from natural history to vaccines and beyond. Caister Academic Press; Wymondham, Norfolk: 2006. pp. 193–212.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources